Thursday June 01, 2023
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International Conference & Exhibition
    • |Cell & Gene Therapy Manufacturing & Commercialization US
    • |Well Characterized Biologics & Biological Assays
    • |Cell & Gene Therapy Manufacturing & Commercialization Europe
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Biosimilars
    • Cell/Gene Therapies
    • Continuous Bioprocessing
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Fill/Finish
    • Formulation
    • Information Technology
    • MAb
    • Manufacturing Contract Services
    • Personalized Medicine
    • Process Monitoring and Controls
    • Single Use
    • Supply Chain
    • Vaccines
    • Validation
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

Read Now Read Now Read Now Listen Now Read Now Learn More

Featured Content

Voices of Biotech: Diversity is about humanity, says Terumo CEO

Terumo’s CEO Antoinette Gawin discusses women in the space, historical bias in the industry, and the importance of hearing every voice.

Read Now

eBook: The Post-Pandemic Supply Chain

The post-pandemic world has taught the industry lessons and forced supply chains to evolve as rising macroeconomic threats emerge.

Read Now

Biopharma 4.0 — the Talent Evolution

A barrier to biopharma industry 4.0 has emerged, but the skills and expertise required to operate technologies are misaligned with the available talent pool.

Read Now

Quantitative Synthetic Biology for Biologics Production

There is a pressing need for innovative CHO–based bioproduction systems to keep pace with biomanufacturing demands.

Read Now

Rapid Identification of Stable Biologic Candidates During Cell Line Development

Sponsored Auraâ„¢ immunoassays bridge cell line development and developability, enabling pre-screening for stability once MAbs secrete from CHO cells.

Read Now

Cell Lines Are the Foundation: A Methodical Approach to Derisking Outsourced Development and Improving Manufacturability of Novel Biologics

Risks associated with product comparability increase as novel biologics move through phases of clinical development toward commercialization.

Read Now

Large-Scale AAV Production: Advantages of an Insect-Cell Baculovirus Expression Vector Platform

Large-scale AAV production remains a major challenge in the field, despite substantial scientific and industrial interest in the AAV vector.

Read Now

Application of an Effective In-Line Analytical Instrument for Biopharmaceutical Development and Manufacture

Sponsored The CTech FlowVPX analytical instrument is an in-line system that can fulfill industry demands, while foregoing human error and solving new challenges.

Read Now

Ask the Expert Webcasts

On-Demand Webcasts

  • Flexible and Customized Approach to Lentiviral Vector Development and Manufacture Through a Well-Established Platform
  • Shaken, Not Stirred: Rocking Motion Versus Impeller Technology and What is Optimal for Cell Cultivation

More >>


BioProcess Insider News and Analysis

@bioprocessintl Tweets

  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Development of IEX Purification Process for Lentiviral Vectors." Date: T… https://t.co/vgK15PE2rB 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/7jyYh7UsoM 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/zokTnEdk6F 2 weeks ago
  • Tweet Avatar Please join us for a #BPIAskTheExpert on "Innovation of Novel Purification Strategies – A Case Study of a Clusterin… https://t.co/lR7nAmnryf 2 weeks ago

Upstream Processing

Quantitative Synthetic Biology for Biologics Production

Shear-Proof Design Space: Scaling Stirred-Tank Bioreactors for Cell Culture Processes

See all in Upstream Processing

Downstream Processing

Viral Safety for Biotechnology Products, Including Viral Vectors: ICH Q5A Revision 2 Brings Updated and More Comprehensive Guidance

Understanding Viral Clearance During Anion-Exchange Chromatography: A Novel Design of Experiments Approach

See all in Downstream Processing

White Papers

Seven Steps to Build a Productive CDMO/Sponsor Relationship

Automated 32×32 Epitope Binning in a Single Assay

Rapid Discovery and Characterization of Monoclonal Antibodies Against the SARS-CoV-2 Delta Spike Protein

Your Ultimate Guide to CMC Testing Support for Gene and Cell Therapy

Cell Harvesting & Washing: Optimizing Viability and Recovery in Cell Therapy

Addressing the Gassing Rate in Bioreactor Upscaling – is vvm a Reliable Parameter?

Integrated Solutions for Advanced Therapies

mRNA Process and Cost Modeling: A Tool to Optimize Process Development

Previous
Next
See all Papers

Manufacturing

eBook: Working Together Is Key to Bioprocess Sustainability

Addressing Gaps in US Biomanufacturing Capacity

See all in Manufacturing

Analytical

Pharmaceutical Manufacturing Quality Assurance Programs: Transitioning from Research and Development to the Clinic

Process Validation: Calculating the Necessary Number of Process Performance Qualification Runs

See all in Analytical

Posters

Accelerating Cell Line Development with an Efficient, Combined Platform Approach

Kuhner TOM For Off-Gas Analysis in Shake Flasks

Evaluation Of a New Glucose Control Strategy Using CITSens Bio APC (Automated Process Control) for CHO Fed-Batch Application

High Productivity and Process Economy in GxP Applications with the Octet™ Platform

Accelerate Cell and Gene Therapy Development and Manufacturing with Fully Integrated Closed CAR-T Cell Therapy Platform

Characterization Platform for Structural and Functional Feature Investigation of Bispecific Molecules

Automated Cell Line Development With Greater Than 99% Monoclonality On the Beacon® Platform

High Titer Recombinant Lentivirus and Adeno-associated Virus Production for Therapeutic Applications

Previous
Next
See all Posters

Webinars

Development of an IEX Purification Process for Lentiviral Vectors

Innovation of Novel Purification Strategies – A Case Study of a Clusterin Scavenger Resin

Advanced Orthogonal Methods to Fully Characterize Process Host Cell Proteins

ELEVECTATM — Truly Stable and Inducible Producer Cell Line for Large Scale AAV Manufacturing

Advances in Bioanalytical Tools for the Characterization of In-Process Viral Samples

MAb Purification Process Development Using Mixed-Mode Resins — The DOE Approach

New Generation Planova™ S20N Demonstrates Robust Performance for Multi-Specific Antibodies

Advantages of Mixed-Mode Chromatography in Host Cell Protein Removal

Previous
Next
See all Webinars

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2023 BioProcess International All Rights reserved
  • Home
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International Conference & Exhibition
    • Cell & Gene Therapy Manufacturing & Commercialization US
    • Well Characterized Biologics & Biological Assays
    • Cell & Gene Therapy Manufacturing & Commercialization Europe
  • BioProcess International Academy
  • Events